TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmbiotech Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover | 19,134 | 429 | 0 |
Financial expenses | 137 | 0 | |
Earnings before taxes | 5,396 | 1,717 | -48 |
Total assets | 7,280 | 23,833 | 22,961 |
Current assets | 3,521 | 3,590 | 18,964 |
Current liabilities | 19 | 18,508 | 19,069 |
Equity capital | 77 | 155 | 86 |
- share capital | 29 | 27 | 29 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency | 1.1% | 0.7% | 0.4% |
Turnover per employee | |||
Profit as a percentage of turnover | 28.2% | 400.2% | |
Return on assets (ROA) | 7.8% | -0.2% | |
Current ratio | 18531.6% | 19.4% | 99.4% |
Return on equity (ROE) | 7007.8% | 1107.7% | -55.8% |
Change turnover | 18,684 | 429 | |
Change turnover % | 4155% | ||
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.